These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. Bauer IH; Reams GP; Wu Z; Lau-Sieckman A J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905 [TBL] [Abstract][Full Text] [Related]
16. Fenofibrate: a review of its use in dyslipidaemia. McKeage K; Keating GM Drugs; 2011 Oct; 71(14):1917-46. PubMed ID: 21942979 [TBL] [Abstract][Full Text] [Related]
17. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751 [TBL] [Abstract][Full Text] [Related]
18. Statins and the liver. Herrick C; Bahrainy S; Gill EA Cardiol Clin; 2015 May; 33(2):257-65. PubMed ID: 25939298 [TBL] [Abstract][Full Text] [Related]
19. Digitalis toxicity: a fading but crucial complication to recognize. Yang EH; Shah S; Criley JM Am J Med; 2012 Apr; 125(4):337-43. PubMed ID: 22444097 [TBL] [Abstract][Full Text] [Related]
20. Inotropes. Francis GS; Bartos JA; Adatya S J Am Coll Cardiol; 2014 May; 63(20):2069-2078. PubMed ID: 24530672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]